MicroRNA-103 regulates the progression in endometrial carcinoma through ZO-1.
In conclusion, miR-103 could regulate EC cell proliferation through directly targeting ZO-1. Our results provide a potential development of microRNA-based targeted approaches for the treatment of EC.
PMID: 31456452 [PubMed - in process]
Source: International Journal of Immunopathology and Pharmacology - Category: Allergy & Immunology Tags: Int J Immunopathol Pharmacol Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Endometrial Cancer | Study